cardiovascular diseases Clinical Trials and Research
Also known as: heart disease, vascular disease, cvd, circulatory system diseases, atherosclerotic disease · ICD-10: I00-I99
Cardiovascular diseases encompass conditions affecting the heart and blood vessels, such as heart attacks, strokes, and heart failure. Clinical trial research aims to improve prevention, diagnosis, and treatment for these widespread conditions. Find a Trial helps patients search for active studies.
Search cardiovascular diseases trials →
Common questions about cardiovascular diseases clinical trials
What are clinical trials for cardiovascular diseases?
Clinical trials for cardiovascular diseases are research studies that test new ways to prevent, detect, or treat heart and blood vessel conditions. They evaluate the safety and effectiveness of new medications, devices, or lifestyle interventions, drawing data from sources like ClinicalTrials.gov.
Who can participate in cardiovascular disease clinical trials?
Eligibility criteria vary greatly by study, often considering factors like age, specific diagnosis, and overall health. Researchers carefully define who can participate to ensure safety and gather relevant data, as seen in studies listed on ClinicalTrials.gov.
What are the different phases of cardiovascular disease clinical trials?
Clinical trials typically progress through phases: Phase 1 tests safety, Phase 2 evaluates effectiveness and side effects, Phase 3 compares new treatments to existing ones, and Phase 4 monitors long-term effects. This structured approach helps ensure rigorous evaluation, as outlined by NIH RePORTER.
Do clinical trials for heart conditions cost money to participate in?
Generally, participants in clinical trials do not pay for the experimental treatment or study-related tests. Some trials may even offer compensation for time and travel. However, standard medical care costs might still apply, as detailed in study protocols on ClinicalTrials.gov.
What types of cardiovascular diseases are being studied in clinical trials?
Clinical trials investigate a wide range of cardiovascular diseases, including coronary artery disease, heart failure, stroke, hypertension, and arrhythmias. Research often focuses on specific patient populations or disease stages, as evidenced by studies on ClinicalTrials.gov.
What are common research directions in cardiovascular disease trials?
Current research directions often include developing novel drugs for cholesterol or blood pressure, new surgical techniques, advanced imaging methods, and gene therapies. Many studies also explore lifestyle interventions and personalized medicine approaches, as funded by NIH RePORTER.
What are some common interventions tested in cardiovascular disease trials?
Interventions can include new medications (e.g., for blood pressure, cholesterol, anticoagulation), medical devices (e.g., stents, pacemakers), surgical procedures, and lifestyle modifications (e.g., diet, exercise programs). These are rigorously evaluated for safety and efficacy, according to ClinicalTrials.gov.
Are there specific biomarkers important in cardiovascular disease research?
Yes, biomarkers like troponin, natriuretic peptides, and inflammatory markers are crucial for diagnosing, monitoring, and predicting outcomes in cardiovascular diseases. Research also explores genetic markers to understand disease susceptibility and treatment response, as studied by NIH RePORTER.
How to find a cardiovascular diseases trial that fits you
- Describe your cardiovascular diseases situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all cardiovascular diseases trials →